Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Value investing focuses on finding undervalued assets for higher returns. Learn effective strategies to enhance your investment portfolio.
26,852 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
On July 22, AI-driven hardware names moved the dial as SMCI posted a surprising margin beat and a burst of orders. Th...
Meme coins linked to a president jumped on headlines about alien disclosure, led by the TRUMP token. The move faded a...
August earnings looms for Nvidia and AMD. This guide helps you understand potential market moves and how to position ...
Tesla beat market expectations with stronger-than-forecast Q4 results, sending shares higher as investors weigh the c...
Warner Bros. Discovery has ruled Paramount's bid superior, setting a tight four-day window for Netflix to respond as ...
Analysts project XRP could climb to multi-dollar levels by 2030, but the path hinges on regulatory outcomes and Rippl...
A global CEO survey shows a shift away from junior roles as companies deploy AI. The move, echoed by Harvard findings...
Q1 2026 results reveal a split: Visa grows through processing scale while Mastercard expands margins with new revenue...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...
A surprise stake in Marriott Vacations Worldwide has investors weighing whether marriott stock after capital offers a...
A leading hedge fund investor says the current AI rally is fundamentally different from the late-1990s bubble, citing...